GAVILYTE-N
Active substance: POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE
POWDER, FOR SOLUTION · POLYETHYLENE GLYCOL 3350 420 g/438.4g, SODIUM CHLORIDE 11.2 g/438.4g, SODIUM BICARBONATE 5.72 g/438.4g, POTASSIUM CHLORIDE 1.48 g/438.4g
United StatesActive
Marketing holder: Lupin Pharmaceuticals,Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- POLYETHYLENE GLYCOL 3350 · 420 g/438.4g
- SODIUM CHLORIDE · 11.2 g/438.4g
- SODIUM BICARBONATE · 5.72 g/438.4g
- POTASSIUM CHLORIDE · 1.48 g/438.4g
Registration
- Registration number
- 43386-050
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 43386-050 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 43386-050 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 43386-050 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 43386-050 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 43386-050 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 43386-050 · Verified 2026-10-09 · open in source